Independent drug action and its statistical implications for development of combination therapies

2020/08/24 by Cong Chen, Fang Liu, Yixin Ren +4 · 1 citation
Computer Science · Immunology and Microbiology · Mathematics · #Biosimilars and Bioanalytical Methods #Computational Drug Discovery Methods #Statistical Methods in Clinical Trials

paper · doi:10.1016/j.cct.2020.106126

openalex publication_date 2020/08/24 · crossref created 2020/08/24 · crossref issued 2020/11/01 · crossref published 2020/11/01 · crossref published-print 2020/11/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/27 · crossref indexed 2025/12/09 · openalex updated_date 2026/07/28

Citations

• Experimental design and statistical analysis for three-drug combination studies
• THE TOXICITY OF POISONS APPLIED JOINTLY1
• Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
• Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy

Cited by

• Peter Karl Sorger [wikipedia]